Shalby Ltd. Stock Falls to 52-Week Low of Rs.141.65 Amidst Market Downturn

Mar 09 2026 01:48 PM IST
share
Share Via
Shalby Ltd., a key player in the hospital sector, witnessed its stock price decline to a fresh 52-week low of Rs.141.65 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns.
Shalby Ltd. Stock Falls to 52-Week Low of Rs.141.65 Amidst Market Downturn

Stock Price Movement and Market Context

On 9 Mar 2026, Shalby Ltd. opened sharply lower with a gap down of -2.85%, continuing a reversal after two consecutive days of gains. The stock underperformed its sector by -3.73% and touched an intraday low of Rs.141.65, representing a decline of -6.07% on the day. This new 52-week low contrasts starkly with its 52-week high of Rs.274.50, reflecting a substantial depreciation of nearly 48.5% from its peak.

Shalby’s share price currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downward trend. This technical positioning aligns with the broader market environment, where the Sensex opened down by -2.36% at 77,056.75 and was trading near 77,069.41, down -2.34%. The Sensex itself has been on a three-week losing streak, shedding -6.94% over this period, with the INDIA VIX index hitting a new 52-week high, indicating elevated market volatility.

Financial Performance and Valuation Metrics

Shalby Ltd.’s financial results have contributed to the subdued investor sentiment. The company reported flat results for the quarter ending December 2025, with Profit Before Tax (PBT) declining sharply by -71.14% to Rs.2.00 crores. This contraction in profitability is a key factor behind the stock’s underperformance.

Return on Capital Employed (ROCE) for the half-year period stands at a low 6.10%, the lowest in recent times, while the debt-to-equity ratio has increased to 0.53 times, the highest recorded for the company. Despite this, the company maintains a manageable Debt to EBITDA ratio of 1.18 times, indicating a reasonable ability to service its debt obligations.

Net sales have shown healthy long-term growth, increasing at an annual rate of 23.17%, with operating profit growing at 25.38%. However, profits have fallen by -76.2% over the past year, reflecting margin pressures or other cost factors impacting the bottom line.

This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.

  • - Target price included
  • - Early movement detected
  • - Complete analysis ready

Get Complete Analysis Now →

Relative Performance and Market Positioning

Over the past year, Shalby Ltd. has delivered a total return of -30.36%, significantly underperforming the Sensex, which gained 3.68% during the same period. The stock has also lagged behind the BSE500 index over the last three years, one year, and three months, indicating persistent challenges in maintaining competitive performance.

Despite its size and presence in the hospital sector, domestic mutual funds hold no stake in Shalby Ltd., which may reflect a cautious stance from institutional investors who typically conduct thorough on-the-ground research. This absence of mutual fund participation could be interpreted as a lack of conviction in the company’s near-term prospects at current valuations.

Valuation and Peer Comparison

Shalby Ltd. currently trades at a very attractive valuation, with an Enterprise Value to Capital Employed ratio of 1.4, which is below the average historical valuations of its peers. This discount reflects the market’s cautious view given the company’s recent profit decline and subdued returns on capital.

While the company’s ROCE of 5 is modest, it contributes to the valuation appeal relative to sector averages. However, the combination of declining profitability and elevated debt levels has weighed on investor sentiment, contributing to the stock’s slide to its 52-week low.

Considering Shalby Ltd.? Wait! SwitchER has found potentially better options in Hospital and beyond. Compare this small-cap with top-rated alternatives now!

  • - Better options discovered
  • - Hospital + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Summary of Key Metrics

As of 9 Mar 2026, Shalby Ltd. holds a Mojo Score of 40.0 with a Mojo Grade of Sell, downgraded from Hold on 1 Dec 2025. The company’s market capitalisation grade stands at 3, reflecting its mid-tier size within the hospital sector.

The stock’s day change was -4.18%, and it has underperformed the sector by -3.73% on the day of the new low. The Sensex’s broader weakness and volatility have compounded the pressure on Shalby’s shares, which have been unable to sustain momentum despite recent short-term gains.

While the company demonstrates a strong ability to service debt, the combination of flat recent results, declining profitability, and subdued returns on capital have contributed to the current valuation and price levels.

Market and Sector Environment

The hospital sector, in which Shalby Ltd. operates, has faced mixed conditions, with some peers maintaining stronger growth trajectories and profitability metrics. Shalby’s relative underperformance highlights the challenges it faces in maintaining market share and investor confidence amid sector dynamics.

Overall, the stock’s fall to Rs.141.65 marks a significant milestone in its price journey, reflecting both company-specific factors and broader market pressures that have influenced investor sentiment and valuation.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News